Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.

Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H.

Circulation. 2011 Jun 14;123(23):2736-47. doi: 10.1161/CIRCULATIONAHA.110.009449. No abstract available.

2.

Minimizing the risks of anticoagulants and platelet inhibitors.

Alexander KP, Peterson ED.

Circulation. 2010 May 4;121(17):1960-70. doi: 10.1161/CIRCULATIONAHA.109.853135. Review. No abstract available.

3.
4.

Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.

Andrade C, Sandarsh S, Chethan KB, Nagesh KS.

J Clin Psychiatry. 2010 Dec;71(12):1565-75. doi: 10.4088/JCP.09r05786blu. Review.

PMID:
21190637
6.

Clinical pharmacology of antithrombotic drugs in coronary artery disease.

Fauler J.

Ther Adv Cardiovasc Dis. 2009 Dec;3(6):465-78. doi: 10.1177/1753944709346517. Epub 2009 Sep 2. Review.

PMID:
19726525
7.

Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.

Kandzari DE.

Rev Cardiovasc Med. 2006;7 Suppl 4:S29-37. Review.

PMID:
17224888
8.

Antiplatelet and anticoagulants drugs.

[No authors listed]

Treat Guidel Med Lett. 2008 May;6(69):29-36; quiz 2 p following 36. Review. No abstract available.

PMID:
18443541
9.

The utility of cardiovascular drugs in the treatment of cerebrovascular disease.

Bösel J, Amiri H.

Curr Opin Investig Drugs. 2010 Sep;11(9):1015-24. Review.

PMID:
20730696
10.

Cardiovascular risk associated with interruption of antiplatelet and oral anticoagulation therapy.

Ferreira JS, Gil VM.

Rev Port Cardiol. 2009 Jul-Aug;28(7-8):845-58. Review. English, Portuguese.

11.

Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy.

Barada K, Abdul-Baki H, El Hajj II, Hashash JG, Green PH.

J Clin Gastroenterol. 2009 Jan;43(1):5-12. doi: 10.1097/MCG.0b013e31811edd13. Review.

PMID:
18607297
12.

The challenge of defining bleeding among patients with acute coronary syndromes.

Wallace TW, Rao SV.

Clin Cardiol. 2007 Oct;30(10 Suppl 2):II16-23. Review.

13.

Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.

Levi MM, Eerenberg E, Löwenberg E, Kamphuisen PW.

Neth J Med. 2010 Feb;68(2):68-76. Review.

14.

Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?

Hermosillo AJ, Spinler SA.

Ann Pharmacother. 2008 Jun;42(6):790-805. doi: 10.1345/aph.1K591. Epub 2008 May 13. Review. Erratum in: Ann Pharmacother. 2008 Oct;42(10):1521.

PMID:
18477734
15.

Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation).

Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, Mulroy MF, Rosenquist RW, Rowlingson J, Tryba M, Yuan CS.

Reg Anesth Pain Med. 2003 May-Jun;28(3):172-97. Review. No abstract available.

PMID:
12772135
16.

[Thromboembolism in non-rheumatic atrial fibrillation].

Pengo V.

Haematologica. 2001 Sep;86(9 Suppl):5-11. Review. Italian. No abstract available.

PMID:
11759619
17.

The year in non-ST-segment elevation acute coronary syndrome.

Giugliano RP, Braunwald E.

J Am Coll Cardiol. 2008 Sep 23;52(13):1095-103. doi: 10.1016/j.jacc.2008.07.005. Review. No abstract available.

18.

Antiplatelet agents in cardiovascular disease.

Lopes RD.

J Thromb Thrombolysis. 2011 Apr;31(3):306-9. doi: 10.1007/s11239-011-0558-9. Review.

PMID:
21327512
19.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.

PMID:
21329865
20.

Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.

Arjomand H, Cohen M, Ezekowitz MD.

J Invasive Cardiol. 2004 May;16(5):271-8. Review.

PMID:
15152137

Supplemental Content

Support Center